A carregar...
Erenumab in chronic migraine: Patient-reported outcomes in a randomized double-blind study
OBJECTIVE: To determine the effect of erenumab, a human monoclonal antibody targeting the calcitonin gene-related peptide receptor, on health-related quality of life (HRQoL), headache impact, and disability in patients with chronic migraine (CM). METHODS: In this double-blind, placebo-controlled stu...
Na minha lista:
| Publicado no: | Neurology |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Lippincott Williams & Wilkins
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6537129/ https://ncbi.nlm.nih.gov/pubmed/30996060 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000007452 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|